Pacific Biosciences of California (PACB)

NASDAQ
Currency in USD
1.560
-0.040(-2.50%)
Closed
After Hours
1.580+0.020(+1.282%)
PACB Scorecard
Full Analysis
Quickly burning through cash
Earnings results expected in 5 days
Fair Value
Day's Range
1.5101.585
52 wk Range
1.1606.830
Key Statistics
Edit
Prev. Close
1.6
Open
1.57
Day's Range
1.51-1.585
52 wk Range
1.16-6.83
Volume
6.89M
Average Volume (3m)
10.22M
1-Year Change
-76.18%
Book Value / Share
1.66
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PACB Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
2.979
Upside
+90.97%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales decline in the current year
Show more

Pacific Biosciences Company Profile

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, it provides revio system + sequel systems which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits. The company serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies. It markets its products through a sales force and distribution partners in Asia, Australia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.

Pacific Biosciences of California Earnings Call Summary for Q3/2024

  • Q3 2024 revenue: $40M, up 11% QoQ but down YoY; full-year forecast below $170M
  • Revio platform upgraded with SpaRC chemistry; Vega benchtop sequencer introduced at $169K
  • 22 new Revio customers; total shipments at 247; Q4 revenue expected flat vs Q3
  • Strategic debt exchange with SoftBank; commitment to cash flow positivity by end of 2026
  • Focus on new products, expanding consumables, and improving commercial execution for 2025 growth
Last Updated: 08/11/2024, 20:06
Read Full Transcript

Compare PACB to Peers and Sector

Metrics to compare
PACB
Peers
Sector
Relationship
P/E Ratio
−1.2x−6.0x−0.6x
PEG Ratio
0.08−0.290.00
Price/Book
1.0x2.2x2.6x
Price / LTM Sales
2.7x4.3x3.1x
Upside (Analyst Target)
80.0%60.0%52.1%
Fair Value Upside
Unlock11.3%8.2%Unlock

Analyst Ratings

7 Buy
8 Hold
0 Sell
Ratings:
15 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 2.979
(+90.97% Upside)

Earnings

Latest Release
Nov 07, 2024
EPS / Forecast
-0.17 / -0.22
Revenue / Forecast
40.00M / 41.95M
EPS Revisions
Last 90 days

People Also Watch

9.2800
QUBT
-3.03%
2.380
IQ
+2.15%
5.810
QBTS
-3.01%
4.150
HUMA
-2.81%
68.96
TEM
+6.11%

FAQ

What Is the Pacific Biosciences (PACB) Stock Price Today?

The Pacific Biosciences stock price today is 1.56

What Stock Exchange Does Pacific Biosciences Trade On?

Pacific Biosciences is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Pacific Biosciences?

The stock symbol for Pacific Biosciences is "PACB."

What Is the Pacific Biosciences Market Cap?

As of today, Pacific Biosciences market cap is 460.60M.

What is Pacific Biosciences Earnings Per Share?

The Pacific Biosciences EPS is -1.46.

What Is the Next Pacific Biosciences Earnings Date?

Pacific Biosciences will release its next earnings report on 13 Feb 2025.

From a Technical Analysis Perspective, Is PACB a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.